Reliance Genemedix Share Discussion Threads

[dodddy] 12/10/2001 23:37

looks like the poo is melting :)

[davidgeran] 12/10/2001 12:43

Role on 20p :-)

[eric bristow] 12/10/2001 12:02

There are simply no buyers of this stock and it's anyones guess at what price they might appear. I suppose a small premium to cash would see buyers in at circa 20 pence but at its present price it wouldn't take many sellers to reach that level IMO.

EB

[davidgeran] 10/10/2001 12:51

Hmmm, the appears to be a theme developing here. Not many going long on this one. Perhaps their Chinese deals are worth something down the line. By the way, anyone know what their cash pile is worth? I think someone mentioned 7p, what does that equate to in overall value?

[eric bristow] 03/10/2001 23:22

It was 300 million when Goodfella first posted. It should be nearer it's cash value ie around 18 million mkt cap but cash burn is an issue too. Mind you based on the CEO's performance on Bloomberg it should be even lower!

EB

[pommy] 03/10/2001 23:06

Mrk Cap = 189.73m not 300mil according to ADVFN!!!!

[adamh] 03/10/2001 12:51

looks to be in a dangerous up trend to me ;¬)





I'm short

[dodddy] 03/10/2001 12:34

oh yeah and its cmc'able but do it slowly in nms otherwise they move the price :)

[eric bristow] 03/10/2001 10:57

Agreed.

The mkt cap is simply staggering especially given sentiment at the moment. Watched the CEO on Bloomberg and he was truely awful. Patel ripped him to pieces and when he asked him about shareholder value (ie why should anyone invest in a company where profits were far off and not even guaranteed at all) the CEO froze and could not answer. It was actually painful to witness and even Patel backed off and gave him soft questions after that.

EB

[lodger] 03/10/2001 10:52

Nice one, already short. They dropped 10% when I shorted them on only 2xNMS :-)

[the player] 03/10/2001 10:50

dodddy,

But, but...........I thought you were already short every stock in the FTSE All Share?

I'm gutted!

TP ;-)

[matthewa] 03/10/2001 10:39

Doddy - Agree with post 100% but don't you think the NMS of 3000 is a little prohibitive?

[dodddy] 03/10/2001 10:17

compliments of goodfella

Despite the recent sell off where many popular stocks have been
hammered many still remain overvalued and some lesser known stocks
have escaped regularly unscathed.

I would suggest this thread to highlight the stocks which could still
have substantial downside.

My suggestion is Genemedix.

Can someone please advise how this company with a 5 year plan and nil
revenue warrants a market cap of near £300 million.

Those biotechs albeit with compelling stories but with with no
visible path to profitability CAT OXG PRM have been whacked in the
last few days but this one seems to have been missed.

And with the US biotech index in freefall nothing is immune

With about 7p of cash and no revenue stream on the horizon this could
have a long way to fall.

I note the major shareholder is DR K.S Tan and would ask is this the
same Dr K S Tan the major shareholder in K S Biomedix another
cutting edge biotech company with minimal revenue stream..

Some large block selling has started and maybe the penny has finally
dropped on this one.



im already short :)

[goodfella] 03/10/2001 09:57

In view of the recent declines in KSB and TXN it is about time GMX was revisited.

All under the management of Dr K S Tan it is a minor miracle how he managed to bring 3 companies to market with a combined value approaching One billion pounds with negligible revenues and some shall we say UNUSUAL ideas.

Although GMX has fallen 35% since I posted with only the odd up-day this should meander its way down to fair value of 15p

[richyrich] 17/8/2001 23:03

Anyone holding these?

I am still holding from its OFEX days as long term investment and I am considering increasing my holding. The company has big ideas for the future and everything, so far, appears to be going to plan. That is why I am interested in the company's presentation to City analysts next week; it looks like a good opportunity to raise the company's profile. This should have a positive effect on the share price.

Does anyone have a view?

[richyrich] 07/8/2001 15:16

News today

GeneMedix plc Interim Results Announcement Date

GeneMedix plc will be announcing interim results for the six months to 31st May 2001 on Tuesday 21st August 2001. There will be a presentation to analysts at 10.30am on that day at College Hill, 78 Cannon Street, London EC4N
6HH.


Does anyone have a view on these result good or bad?

Presumably if the company is making a presentation to analysts they must have something positive to say; any ideas what?

[calleva] 19/7/2001 09:36

08:33, Thur 19 July 2001
GeneMedix gets green light in China
Biopharmaceutical company GeneMedix has got the thumbs up from the Chinese State Drug Administration to sell its treatment for patients suffering from low white blood cell count.

The group's granulocyte macrophage colony stimulating factor is aimed at cancer, transplant and AIDS patients and the company hopes to finalise the product's pricing within the next few months.

The market for such treatments in China is estimated to be worth around $25 million (£17.8 million) a year and this is currently increasing at a rate of more than 20% a year.

To promote the brand GeneMedix has appointed Dr He Huaming, a qualified medical doctor with corporate experience, as sales and marketing director for the region.

Neustim will be GeneMedix's first commercial product and marks the important step from a development company to one bringing in money. The group's local foundations and workforce means GeneMedix also has a good understanding of the region and the way business is conducted. This knowledge should help it roll out further products which include seven commercial treatments over the next five to six years.

GeneMedix focuses on drugs that aren't patented in emerging markets and which are due to go off patent in Western Europe.

The shares (GMX) are unchanged at 84.5p, having topped 114p in January following the flotation last year.


©2001 citywire.co.uk

[eric bristow] 18/5/2001 10:27

2 Million shares just dumped at 3 pence below the bid.

[goodfella] 24/3/2001 11:49

honister.

Ahhhhhhhh EPF I think you know my feelings on that stock, many holding on for the spike on grant of licence but that will be your best chance to get out on this no-hoper

[honister] 23/3/2001 23:13

Thank goodness you didn't attack EPF, I'd be open to paranoia, thought you were following me from the etrade bb..... rgds (RB).


Good health and wealth.

Honister

[costa7] 23/3/2001 23:07

The most overvalued tech stock, is Autonomy, which recently left FTSE 100. With a P/E ratio of around 700.

[bird] 23/3/2001 22:44

Good fella-I would like to data-mine for overvalued stocks.....can you advise on where to research please.

tia.

[keyboard] 23/3/2001 22:24

Have a look at IBT and FLS. They are good investment trusts, which have fallen quite a bit recently and historically have always come back after such falls. Both of them provide one with good exposure to biotechs. It all depends on what one is looking for and how much risk one is prepared to take. Nobody ever said biotechs are for the faint-hearted.

[goodfella] 23/3/2001 09:15

Despite the recent sell off where many popular stocks have been
hammered many still remain overvalued and some lesser known stocks
have escaped regularly unscathed.

I would suggest this thread to highlight the stocks which could still
have substantial downside.

My suggestion is Genemedix.

Can someone please advise how this company with a 5 year plan and nil
revenue warrants a market cap of near £300 million.

Those biotechs albeit with compelling stories but with with no
visible path to profitability CAT OXG PRM have been whacked in the
last few days but this one seems to have been missed.

And with the US biotech index in freefall nothing is immune

With about 7p of cash and no revenue stream on the horizon this could
have a long way to fall.

I note the major shareholder is DR K.S Tan and would ask is this the
same Dr K S Tan the major shareholder in K S Biomedix another
cutting edge biotech company with minimal revenue stream..

Some large block selling has started and maybe the penny has finally
dropped on this one.